{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T04:50:58Z","timestamp":1782190258339,"version":"3.54.5"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,22]]},"DOI":"10.7759\/cureus.111331","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T04:39:27Z","timestamp":1782189567000},"source":"Crossref","is-referenced-by-count":0,"title":["Hemato-Oncology Care During and After the COVID-19 Pandemic: Changes in Treatment Pathways, Patient Flow, and Durable Organizational Adaptations"],"prefix":"10.7759","author":[{"given":"Paul C","family":"Toboltoc","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioana","family":"Gagiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex L","family":"Lukusa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adela","family":"Vekony","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/s43018-020-0074-y","article-title":"The impact of the COVID-19 pandemic on cancer care","volume":"1","author":"Richards M","year":"2020","unstructured":"Richards M, Anderson M, Carter P, Ebert BL, Mossialos E. The impact of the COVID-19 pandemic on cancer care. Nat Cancer. 2020, 1:565-7. 10.1038\/s43018-020-0074-y","journal-title":"Nat Cancer"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/s43018-024-00880-4","article-title":"The global impact of the COVID-19 pandemic on delays and disruptions in cancer care services: a systematic review and meta-analysis","volume":"6","author":"Shah R","year":"2025","unstructured":"Shah R, Hanna NM, Loo CE, et al.. The global impact of the COVID-19 pandemic on delays and disruptions in cancer care services: a systematic review and meta-analysis. Nat Cancer. 2025, 6:194-204. 10.1038\/s43018-024-00880-4","journal-title":"Nat Cancer"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(20)30251-9","article-title":"Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study","volume":"7","author":"Passamonti F","year":"2020","unstructured":"Passamonti F, Cattaneo C, Arcaini L, et al.. Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study. Lancet Haematol. 2020, 7:e737-45. 10.1016\/S2352-3026(20)30251-9","journal-title":"Lancet Haematol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020008824","article-title":"Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients","volume":"136","author":"Vijenthira A","year":"2020","unstructured":"Vijenthira A, Gong IY, Fox TA, et al.. Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients. Blood. 2020, 136:2881-92. 10.1182\/blood.2020008824","journal-title":"Blood"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2022.100403","article-title":"Managing hematological cancer patients during the COVID-19 pandemic: an ESMO-EHA interdisciplinary expert consensus","volume":"7","author":"Buske C","year":"2022","unstructured":"Buske C, Dreyling M, Alvarez-Larr\u00e1n A, et al.. Managing hematological cancer patients during the COVID-19 pandemic: an ESMO-EHA interdisciplinary expert consensus. ESMO Open. 2022, 7:100403. 10.1016\/j.esmoop.2022.100403","journal-title":"ESMO Open"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.01439","article-title":"Management of patients with hematologic malignancies during the COVID-19 pandemic: practical considerations and lessons to be learned","volume":"10","author":"Isidori A","year":"2020","unstructured":"Isidori A, de Leval L, Gergis U, Musto P, Porcu P. Management of patients with hematologic malignancies during the COVID-19 pandemic: practical considerations and lessons to be learned. Front Oncol. 2020, 10:1439. 10.3389\/fonc.2020.01439","journal-title":"Front Oncol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020002120","article-title":"Ensuring continuity of care of hematologic patients during COVID-19 pandemic in a tertiary hospital in Lombardy (Italy)","volume":"4","author":"Fattizzo B","year":"2020","unstructured":"Fattizzo B, Giannotta JA, Barcellini W, et al.. Ensuring continuity of care of hematologic patients during COVID-19 pandemic in a tertiary hospital in Lombardy (Italy). Blood Adv. 2020, 4:2996-9. 10.1182\/bloodadvances.2020002120","journal-title":"Blood Adv"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.01183","article-title":"Treating hematologic malignancies during a pandemic: utilizing telehealth and digital technology to optimize care","volume":"10","author":"Binder AF","year":"2020","unstructured":"Binder AF, Handley NR, Wilde L, Palmisiano N, Lopez AM. Treating hematologic malignancies during a pandemic: utilizing telehealth and digital technology to optimize care. Front Oncol. 2020, 10:1183. 10.3389\/fonc.2020.01183","journal-title":"Front Oncol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(20)30388-0","article-title":"The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study","volume":"21","author":"Maringe C","year":"2020","unstructured":"Maringe C, Spicer J, Morris M, et al.. The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study. Lancet Oncol. 2020, 21:1023-34. 10.1016\/S1470-2045(20)30388-0","journal-title":"Lancet Oncol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(20)30392-2","article-title":"Effect of delays in the 2-week-wait cancer referral pathway during the COVID-19 pandemic on cancer survival in the UK: a modelling study","volume":"21","author":"Sud A","year":"2020","unstructured":"Sud A, Torr B, Jones ME, et al.. Effect of delays in the 2-week-wait cancer referral pathway during the COVID-19 pandemic on cancer survival in the UK: a modelling study. Lancet Oncol. 2020, 21:1035-44. 10.1016\/S1470-2045(20)30392-2","journal-title":"Lancet Oncol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3390\/curroncol29020076","article-title":"The use of virtual care in patients with hematologic malignancies: a scoping review","volume":"29","author":"Suleman A","year":"2022","unstructured":"Suleman A, Vijenthira A, Berlin A, Prica A, Rodin D. The use of virtual care in patients with hematologic malignancies: a scoping review. Curr Oncol. 2022, 29:892-900. 10.3390\/curroncol29020076","journal-title":"Curr Oncol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s10238-024-01381-5","article-title":"Managing and treating COVID-19 in patients with hematological malignancies: a narrative review and expert insights","volume":"24","author":"Ng HJ","year":"2024","unstructured":"Ng HJ, Alata MK, Nguyen QT, Huynh Duc Vinh P, Tan JY, Wong CL. Managing and treating COVID-19 in patients with hematological malignancies: a narrative review and expert insights. Clin Exp Med. 2024, 24:119. 10.1007\/s10238-024-01381-5","journal-title":"Clin Exp Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2021.280163","article-title":"Antibody response after vaccination against SARS-CoV-2 in adults with hematological malignancies: a systematic review and meta-analysis","volume":"107","author":"Gagelmann N","year":"2022","unstructured":"Gagelmann N, Passamonti F, Wolschke C, et al.. Antibody response after vaccination against SARS-CoV-2 in adults with hematological malignancies: a systematic review and meta-analysis. Haematologica. 2022, 107:1840-9. 10.3324\/haematol.2021.280163","journal-title":"Haematologica"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1186\/s41073-019-0064-8","article-title":"SANRA-a scale for the quality assessment of narrative review articles","volume":"4","author":"Baethge C","year":"2019","unstructured":"Baethge C, Goldbeck-Wood S, Mertens S. SANRA-a scale for the quality assessment of narrative review articles. Res Integr Peer Rev. 2019, 4:5. 10.1186\/s41073-019-0064-8","journal-title":"Res Integr Peer Rev"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2021.01.004","article-title":"Treatment of acute leukemia during COVID- 19: focused review of evidence","volume":"21","author":"Singh S","year":"2021","unstructured":"Singh S, Singh J, Paul D, Jain K. Treatment of acute leukemia during COVID- 19: focused review of evidence. Clin Lymphoma Myeloma Leuk. 2021, 21:289-94. 10.1016\/j.clml.2021.01.004","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s11899-021-00642-4","article-title":"Use of telemedicine in care of hematologic malignancy patients: challenges and opportunities","volume":"17","author":"Lloyd J","year":"2022","unstructured":"Lloyd J, Lee CJ. Use of telemedicine in care of hematologic malignancy patients: challenges and opportunities. Curr Hematol Malig Rep. 2022, 17:25-30. 10.1007\/s11899-021-00642-4","journal-title":"Curr Hematol Malig Rep"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ypmed.2021.106559","article-title":"COVID-19 impact on screening test volume through the National Breast and Cervical Cancer early detection program, January-June 2020, in the United States","volume":"151","author":"DeGroff A","year":"2021","unstructured":"DeGroff A, Miller J, Sharma K, et al.. COVID-19 impact on screening test volume through the National Breast and Cervical Cancer early detection program, January-June 2020, in the United States. Prev Med. 2021, 151:106559. 10.1016\/j.ypmed.2021.106559","journal-title":"Prev Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare13192520","article-title":"Impact of the COVID-19 pandemic on hemato-oncology services: a retrospective dual-center cohort study in Kazakhstan","volume":"13","author":"Yerdenova M","year":"2025","unstructured":"Yerdenova M, Izekenova A, Myrkassymova A, et al.. Impact of the COVID-19 pandemic on hemato-oncology services: a retrospective dual-center cohort study in Kazakhstan. Healthcare (Basel). 2025, 13:10.3390\/healthcare13192520","journal-title":"Healthcare (Basel)"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m4087","article-title":"Mortality due to cancer treatment delay: systematic review and meta-analysis","volume":"371","author":"Hanna TP","year":"2020","unstructured":"Hanna TP, King WD, Thibodeau S, et al.. Mortality due to cancer treatment delay: systematic review and meta-analysis. BMJ. 2020, 371:m4087. 10.1136\/bmj.m4087","journal-title":"BMJ"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2021.05.012","article-title":"Impact of COVID-19 on healthcare organisation and cancer outcomes","volume":"153","author":"Bardet A","year":"2021","unstructured":"Bardet A, Fraslin AM, Marghadi J, et al.. Impact of COVID-19 on healthcare organisation and cancer outcomes. Eur J Cancer. 2021, 153:123-32. 10.1016\/j.ejca.2021.05.012","journal-title":"Eur J Cancer"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2024.102553","article-title":"Decoding the historical tale: COVID-19 impact on haematological malignancy patients-EPICOVIDEHA insights from 2020 to 2022","volume":"71","author":"Salmanton-Garc\u00eda J","year":"2024","unstructured":"Salmanton-Garc\u00eda J, Marchesi F, Farina F, et al.. Decoding the historical tale: COVID-19 impact on haematological malignancy patients-EPICOVIDEHA insights from 2020 to 2022. EClinicalMedicine. 2024, 71:102553. 10.1016\/j.eclinm.2024.102553","journal-title":"EClinicalMedicine"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16020379","article-title":"COVID-19 outcomes in patients with hematologic malignancies in the era of COVID-19 vaccination and the Omicron variant","volume":"16","author":"Mart\u00ednez-L\u00f3pez J","year":"2024","unstructured":"Mart\u00ednez-L\u00f3pez J, de la Cruz J, Gil-Manso R, et al.. COVID-19 outcomes in patients with hematologic malignancies in the era of COVID-19 vaccination and the Omicron variant. Cancers (Basel). 2024, 16:10.3390\/cancers16020379","journal-title":"Cancers (Basel)"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020003170","article-title":"Outcomes of patients with hematologic malignancies and COVID- 19: a report from the ASH Research Collaborative Data Hub","volume":"4","author":"Wood WA","year":"2020","unstructured":"Wood WA, Neuberg DS, Thompson JC, et al.. Outcomes of patients with hematologic malignancies and COVID- 19: a report from the ASH Research Collaborative Data Hub. Blood Adv. 2020, 4:5966-75. 10.1182\/bloodadvances.2020003170","journal-title":"Blood Adv"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-025-02649-9","article-title":"Post-pandemic recommendations for the management of COVID-19 in patients with haematological malignancies or undergoing cellular therapy, from the European Conference on Infections in Leukaemia (ECIL-10)","volume":"39","author":"Cesaro S","year":"2025","unstructured":"Cesaro S, Ljungman P, Mikulska M, et al.. Post-pandemic recommendations for the management of COVID-19 in patients with haematological malignancies or undergoing cellular therapy, from the European Conference on Infections in Leukaemia (ECIL-10). Leukemia. 2025, 39:2061-71. 10.1038\/s41375-025-02649-9","journal-title":"Leukemia"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2021.280407","article-title":"Prolonged viral replication in patients with hematologic malignancies hospitalized with COVID-19","volume":"107","author":"Garcia-Vidal C","year":"2022","unstructured":"Garcia-Vidal C, Puerta-Alcalde P, Mateu A, et al.. Prolonged viral replication in patients with hematologic malignancies hospitalized with COVID-19. Haematologica. 2022, 107:1731-5. 10.3324\/haematol.2021.280407","journal-title":"Haematologica"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.564383","article-title":"Changing management of hematological malignancies with COVID- 19: statement and recommendations of the Lebanese Society of Hematology and Blood Transfusion","volume":"11","author":"Ibrahim A","year":"2021","unstructured":"Ibrahim A, Noun P, Khalil C, Taher A. Changing management of hematological malignancies with COVID- 19: statement and recommendations of the Lebanese Society of Hematology and Blood Transfusion. Front Oncol. 2021, 11:564383. 10.3389\/fonc.2021.564383","journal-title":"Front Oncol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-020-0970-x","article-title":"Management of patients with acute leukemia during the COVID-19 outbreak: practical guidelines from the acute leukemia working party of the European Society for Blood and Marrow Transplantation","volume":"56","author":"Brissot E","year":"2021","unstructured":"Brissot E, Labopin M, Baron F, et al.. Management of patients with acute leukemia during the COVID-19 outbreak: practical guidelines from the acute leukemia working party of the European Society for Blood and Marrow Transplantation. Bone Marrow Transplant. 2021, 56:532-5. 10.1038\/s41409-020-0970-x","journal-title":"Bone Marrow Transplant"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-022-01604-x","article-title":"Impact of the SARS-CoV-2 pandemic on hematopoietic cell transplantation and cellular therapies in Europe 2020: a report from the EBMT activity survey","volume":"57","author":"Passweg JR","year":"2022","unstructured":"Passweg JR, Baldomero H, Chabannon C, et al.. Impact of the SARS-CoV-2 pandemic on hematopoietic cell transplantation and cellular therapies in Europe 2020: a report from the EBMT activity survey. Bone Marrow Transplant. 2022, 57:742-52. 10.1038\/s41409-022-01604-x","journal-title":"Bone Marrow Transplant"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-023-01943-3","article-title":"Hematopoietic cell transplantation and cellular therapies in Europe 2021. The second year of the SARS-CoV-2 pandemic. A report from the EBMT Activity Survey","volume":"58","author":"Passweg JR","year":"2023","unstructured":"Passweg JR, Baldomero H, Ciceri F, et al.. Hematopoietic cell transplantation and cellular therapies in Europe 2021. The second year of the SARS-CoV-2 pandemic. A report from the EBMT Activity Survey. Bone Marrow Transplant. 2023, 58:647-58. 10.1038\/s41409-023-01943-3","journal-title":"Bone Marrow Transplant"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-020-0919-0","article-title":"The challenge of COVID-19 and hematopoietic cell transplantation; EBMT recommendations for management of hematopoietic cell transplant recipients, their donors, and patients undergoing CAR T-cell therapy","volume":"55","author":"Ljungman P","year":"2020","unstructured":"Ljungman P, Mikulska M, de la Camara R, et al.. The challenge of COVID-19 and hematopoietic cell transplantation; EBMT recommendations for management of hematopoietic cell transplant recipients, their donors, and patients undergoing CAR T-cell therapy. Bone Marrow Transplant. 2020, 55:2071-6. 10.1038\/s41409-020-0919-0","journal-title":"Bone Marrow Transplant"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.17280","article-title":"The NICE COVID-19 rapid guideline on haematopoietic stem cell transplantation: development, implementation and impact","volume":"192","author":"Orchard K","year":"2021","unstructured":"Orchard K, Dignan FL, Lee J, et al.. The NICE COVID-19 rapid guideline on haematopoietic stem cell transplantation: development, implementation and impact. Br J Haematol. 2021, 192:467-73. 10.1111\/bjh.17280","journal-title":"Br J Haematol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-021-01227-8","article-title":"Hematopoietic cell transplantation and cellular therapy survey of the EBMT: monitoring of activities and trends over 30 years","volume":"56","author":"Passweg JR","year":"2021","unstructured":"Passweg JR, Baldomero H, Chabannon C, et al.. Hematopoietic cell transplantation and cellular therapy survey of the EBMT: monitoring of activities and trends over 30 years. Bone Marrow Transplant. 2021, 56:1651-64. 10.1038\/s41409-021-01227-8","journal-title":"Bone Marrow Transplant"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1200\/OP.22.00690","article-title":"Virtual care during the COVID-19 pandemic for patients with hematologic malignancies: a single-institution experience","volume":"19","author":"Suleman A","year":"2023","unstructured":"Suleman A, Vijenthira A, Liu ZA, Truong T, Berlin A, Prica A, Rodin D. Virtual care during the COVID-19 pandemic for patients with hematologic malignancies: a single-institution experience. JCO Oncol Pract. 2023, 19:e672-82. 10.1200\/OP.22.00690","journal-title":"JCO Oncol Pract"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2020.6982","article-title":"Implementation and outcomes of virtual care across a tertiary cancer center during COVID-19","volume":"7","author":"Berlin A","year":"2021","unstructured":"Berlin A, Lovas M, Truong T, et al.. Implementation and outcomes of virtual care across a tertiary cancer center during COVID-19. JAMA Oncol. 2021, 7:597-602. 10.1001\/jamaoncol.2020.6982","journal-title":"JAMA Oncol"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2020.2684","article-title":"Telemedicine for cancer care in the time of COVID-19","volume":"6","author":"Royce TJ","year":"2020","unstructured":"Royce TJ, Sanoff HK, Rewari A. Telemedicine for cancer care in the time of COVID-19. JAMA Oncol. 2020, 6:1698-9. 10.1001\/jamaoncol.2020.2684","journal-title":"JAMA Oncol"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1002\/cnr2.1358","article-title":"The direct and indirect effects of COVID-19 pandemic in a real-life hematological setting","volume":"4","author":"Condom M","year":"2021","unstructured":"Condom M, Mussetti A, Maluquer C, et al.. The direct and indirect effects of COVID-19 pandemic in a real-life hematological setting. Cancer Rep (Hoboken). 2021, 4:e1358. 10.1002\/cnr2.1358","journal-title":"Cancer Rep (Hoboken)"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(20)30176-9","article-title":"Following-up allogeneic transplantation recipients during the COVID-19 pandemic","volume":"7","author":"Lupo-Stanghellini MT","year":"2020","unstructured":"Lupo-Stanghellini MT, Messina C, Marktel S, Carrabba MG, Peccatori J, Corti C, Ciceri F. Following-up allogeneic transplantation recipients during the COVID-19 pandemic. Lancet Haematol. 2020, 7:e564-5. 10.1016\/S2352-3026(20)30176-9","journal-title":"Lancet Haematol"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2020.02.004","article-title":"Pilot study of telehealth evaluations in patients undergoing hematopoietic cell transplantation","volume":"26","author":"Nawas MT","year":"2020","unstructured":"Nawas MT, Landau HJ, Sauter CS, et al.. Pilot study of telehealth evaluations in patients undergoing hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2020, 26:e135-7. 10.1016\/j.bbmt.2020.02.004","journal-title":"Biol Blood Marrow Transplant"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-015-1287-9","article-title":"A longitudinal study of non-medical determinants of adherence to R-CHOP therapy for diffuse large B-cell lymphoma: implication for survival","volume":"15","author":"Borel C","year":"2015","unstructured":"Borel C, Lamy S, Compaci G, et al.. A longitudinal study of non-medical determinants of adherence to R-CHOP therapy for diffuse large B-cell lymphoma: implication for survival. BMC Cancer. 2015, 15:288. 10.1186\/s12885-015-1287-9","journal-title":"BMC Cancer"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.3332\/ecancer.2020.ed104","article-title":"Rapidly established telehealth care for blood cancer patients in Nepal during the COVID-19 pandemic using the free app Viber","volume":"14","author":"Poudyal BS","year":"2020","unstructured":"Poudyal BS, Gyawali B, Rondelli D. Rapidly established telehealth care for blood cancer patients in Nepal during the COVID-19 pandemic using the free app Viber. Ecancermedicalscience. 2020, 14:ed104. 10.3332\/ecancer.2020.ed104","journal-title":"Ecancermedicalscience"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.18103\/mra.v12i2.5164","article-title":"Racial disparities in telemedicine uptake during the COVID-19 pandemic among patients with hematologic malignancies in the United States","volume":"12","author":"Neparidze N","year":"2024","unstructured":"Neparidze N, Lau K, Wang X, et al.. Racial disparities in telemedicine uptake during the COVID-19 pandemic among patients with hematologic malignancies in the United States. Med Res Arch. 2024, 12:10.18103\/mra.v12i2.5164","journal-title":"Med Res Arch"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.2196\/65147","article-title":"Factors associated with the availability of virtual consultations in primary care across 20 countries: cross-sectional study","volume":"27","author":"Kerr G","year":"2025","unstructured":"Kerr G, Greenfield G, Li E, et al.. Factors associated with the availability of virtual consultations in primary care across 20 countries: cross-sectional study. J Med Internet Res. 2025, 27:e65147. 10.2196\/65147","journal-title":"J Med Internet Res"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1093\/jamia\/ocaa067","article-title":"Telehealth transformation: COVID-19 and the rise of virtual care","volume":"27","author":"Wosik J","year":"2020","unstructured":"Wosik J, Fudim M, Cameron B, et al.. Telehealth transformation: COVID-19 and the rise of virtual care. J Am Med Inform Assoc. 2020, 27:957-62. 10.1093\/jamia\/ocaa067","journal-title":"J Am Med Inform Assoc"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1038\/s43018-021-00274-w","article-title":"Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: the CAPTURE study","volume":"2","author":"Fendler A","year":"2021","unstructured":"Fendler A, Shepherd ST, Au L, et al.. Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: the CAPTURE study. Nat Cancer. 2021, 2:1321-37. 10.1038\/s43018-021-00274-w","journal-title":"Nat Cancer"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-022-01233-3","article-title":"Serologic response following SARS-COV2 vaccination in patients with cancer: a systematic review and meta-analysis","volume":"15","author":"Sakuraba A","year":"2022","unstructured":"Sakuraba A, Luna A, Micic D. Serologic response following SARS-COV2 vaccination in patients with cancer: a systematic review and meta-analysis. J Hematol Oncol. 2022, 15:15. 10.1186\/s13045-022-01233-3","journal-title":"J Hematol Oncol"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2021004629","article-title":"Vaccine response following anti-CD20 therapy: a systematic review and meta-analysis of 905 patients","volume":"5","author":"Vijenthira A","year":"2021","unstructured":"Vijenthira A, Gong I, Betschel SD, Cheung M, Hicks LK. Vaccine response following anti-CD20 therapy: a systematic review and meta-analysis of 905 patients. Blood Adv. 2021, 5:2624-43. 10.1182\/bloodadvances.2021004629","journal-title":"Blood Adv"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/505188-hemato-oncology-care-during-and-after-the-covid-19-pandemic-changes-in-treatment-pathways-patient-flow-and-durable-organizational-adaptations","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T04:39:31Z","timestamp":1782189571000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/505188-hemato-oncology-care-during-and-after-the-covid-19-pandemic-changes-in-treatment-pathways-patient-flow-and-durable-organizational-adaptations"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,22]]},"references-count":46,"URL":"https:\/\/doi.org\/10.7759\/cureus.111331","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6,22]]}}}